YouTube video by BlackArmor

Switzerland-based Icotec received FDA clearance to expand use of its CMORE CT system in the cervicothoracic region.  The system includes polyaxial screws, rods and connectors designed for posterior stabilization of the upper spine. The implant is made from the company’s radiolucent, nonmetallic BlackArmor material and supports artifact-free imaging across MRI, CT and X-ray, according to […]

Das Schweizer Medizintechnik-Unternehmen icotec hat von der US-amerikanischen Arzneimittelbehörde FDA die Zulassung für das CMORE®CT-System erhalten. Damit wird die BlackArmor® Engineered Carbon/PEEK-Technologie erstmals auf die posteriore Stabilisierung im zervikothorakalen Bereich der Wirbelsäule ausgeweitet. Das System umfasst ein vollständiges Instrumentarium und Implantatportfolio mit polyaxialen Schrauben, geraden sowie vorgeformten Stäben und axialen beziehungsweise parallelen Verbindungselementen. Es ermöglicht Chirurgen eine flexible Anpassung an unterschiedliche anatomische und pathologische Bedingungen.

icotec announces FDA clearance for the CMORE® CT System, marking a significant advancement in BlackArmor® technology for spinal treatments.

The FDA has granted icotec approval for its CMORE® CT system, enhancing spinal treatment options and imaging capabilities with advanced technology.

icotec has announced FDA approval for its CMORE® CT system, advancing its BlackArmor® carbon/PEEK technology for cervical-thoracic spine applications.

(Información remitida por la empresa firmante) -- icotec recibe la autorización de la FDA para el sistema CMORE® CT, ampliando su tecnología BlackArmor® de carbono/PEEK a la columna cervicotorácica posterior ALTSTÄTTEN, Suiza y BOSTON, 13 de noviembre de 2025 /PRNewswire/ -- icotec, pionera en dispositivos implantables fabricados con BlackArmor® Engineered Carbon/PEEK, anunció hoy que la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) ha autorizado el uso del sistema CMORE® CT en la columna cervicotorácica.

ALTSTÄTTEN, Switzerland and BOSTON, Nov. 14, 2025 /PRNewswire/ — icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT System for use in the cervicothoracic spine. CMORE CT System Receives FDA Clearance The CMORE® (CT) System is an enhanced set […]

icotec's CMORE® CT System has received FDA clearance, advancing spinal surgery with its innovative BlackArmor® technology for enhanced imaging and therapy options.

icotec has received FDA clearance for its CMORE® CT System, expanding its BlackArmor® Engineered technology for advanced spine surgery. This innovative system shows promise in treating complex spinal conditions.

ALTSTÄTTEN, Switzerland and BOSTON, Nov. 13, 2025 /PRNewswire/ -- icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT System for use in the cervicothoracic spine....

ALTSTÄTTEN, Switzerland and BOSTON, Nov. 13, 2025 /PRNewswire/ -- icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT System for use in the cervicothoracic spine....

icotec has announced the FDA clearance for BlackArmor® implants, which target spinal infections, marking a significant advancement in spinal surgery.

Icotec proudly announces FDA approval for BlackArmor® implants, designed specifically for treating spinal infections. This advancement marks a significant milestone in spinal surgery.

icotec announces FDA clearance for BlackArmor® implants, aiding in the treatment of spinal infections. A groundbreaking achievement for patient care.

icotec has achieved FDA clearance for BlackArmor® implants to treat spinal infections, marking a significant advancement in spinal care.

icotec has secured FDA clearance for BlackArmor® spinal implants, specifically designed for treating spinal infections. This breakthrough aids thousands of patients annually.